Wellington Management Group
DTIL icon

Wellington Management Group’s Precision BioSciences DTIL Stock Holding History

Wellington Management Group’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-3,146
Closed -$151K – 2051
2022
Q2 		$151K Hold
3,146
– – ﹤0.01% 2024
2022
Q1 		$291K Sell
3,146
-525
-14% -$71.3K ﹤0.01% 2021
2021
Q4 		$815K Buy
+3,671
New +$1.03M ﹤0.01% 1836
2019
Q2 		– Sell
-5,855
Closed -$3.15M – 2071
2019
Q1 		$3.15M Buy
+5,855
New +$3.11M ﹤0.01% 1496

Other funds holding DTIL

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Wellington Management Group's DTIL Position: Q3 2022 in Review

Wellington Management Group sold out of Precision BioSciences (DTIL) in Q3 2022, closing a stake of 3,146 shares — an estimated $151K sold.

Wellington Management Group first reported a position in DTIL in Q1 2019 and held it in 4 quarters. The position peaked at $3.15M in Q1 2019. 102 funds tracked by Wall St. Rank hold DTIL as of Q3 2022.

  • Wellington Management Group reported no remaining Precision BioSciences position as of Q3 2022 after selling out during the quarter.
  • Wellington Management Group sold 3,146 Precision BioSciences shares in Q3 2022, an estimated $151K.
  • Wellington Management Group first reported a position in Precision BioSciences in Q1 2019 and held it in 4 quarters.
  • Wellington Management Group's Precision BioSciences position peaked at $3.15M in Q1 2019.
  • 102 funds tracked by Wall St. Rank held Precision BioSciences as of Q3 2022.

Based on Wellington Management Group's 13F filing for Q3 2022, filed 14 Nov 2022.